C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1994
11/24/1994	WO1994026922A2 Methods and compositions relating to sterol regulatory element binding proteins
11/24/1994	WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/24/1994	WO1994026911A1 A gene expression system utilizing an rna polymerase prebound to dna
11/24/1994	WO1994026910A1 Immunotoxins comprising gelonin and an antibody
11/24/1994	WO1994026907A1 Hippuricase gene
11/24/1994	WO1994026905A1 Immortalized human cell lines containing exogenous cytochrome p450 genes
11/24/1994	WO1994026904A1 Hepatitis b virus mutants, reagents and methods for detection
11/24/1994	WO1994026903A2 Human influenza virus peptides binding hla-i molecule
11/24/1994	WO1994026902A1 Nucleic acids encoding human astrovirus serotype 2 and uses thereof
11/24/1994	WO1994026901A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
11/24/1994	WO1994026900A2 Hybrid picornaviruses expressing chlamydial epitopes
11/24/1994	WO1994026899A1 Method for the culture in vitro of differents stages of tissue parasites
11/24/1994	WO1994026898A1 The synthesized gene encoding for trichosanthin protein
11/24/1994	WO1994026897A2 Dna encoding two fish neuropeptides
11/24/1994	WO1994026896A1 Increased expression of alpha-1-antitrypsin in expression vectors through the inclusion of intron ii
11/24/1994	WO1994026894A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
11/24/1994	WO1994026893A1 Bmp-10 compositions
11/24/1994	WO1994026892A1 Bmp-11 compositions
11/24/1994	WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	WO1994026890A1 Hiv-1 tar rna binding protein
11/24/1994	WO1994026889A2 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
11/24/1994	WO1994026886A2 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
11/24/1994	WO1994026878A1 Expansins, proteins that catalyze plant cell wall expansion and weakening of paper fiber connections
11/24/1994	WO1994026873A1 Yeast strain and methods for expressing heterologous proteins in yeast
11/24/1994	WO1994026786A1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
11/24/1994	WO1994026785A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
11/24/1994	WO1994026783A1 Analysis and modification of protein structure
11/24/1994	WO1994026782A1 PSEUDOMONAS SYRINGAE pv. SYRINGAE hrpZ GENE
11/24/1994	WO1994026781A1 Thermoresistant alpha-1-antitrypsin mutein
11/24/1994	WO1994026779A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS
11/24/1994	WO1994026778A1 Conjugation-stabilized polypeptide compositions
11/24/1994	WO1994026777A1 Thrombin inhibitors
11/24/1994	WO1994026776A1 Therapeutic compounds
11/24/1994	WO1994026774A1 Novel treatments for allergic diseases
11/24/1994	WO1994026773A1 Regulation of antigen presentation
11/24/1994	WO1994026754A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
11/24/1994	WO1994026381A1 Artificial receptors, antibodies, and enzymes
11/24/1994	WO1994026308A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026306A1 Conserved motif of hepatitis c virus e2/ns1 region
11/24/1994	WO1994026305A1 Hiv immunogenic complexes
11/24/1994	WO1994026304A1 Otitis media vaccine
11/24/1994	WO1994026303A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
11/24/1994	WO1994026298A1 Methods for treating muscle diseases and disorders
11/24/1994	WO1994026296A1 Novel opioid peptide inhibitors
11/24/1994	WO1994026295A1 Metal chelates as spacer compounds in biologically active peptides
11/24/1994	WO1994026292A1 Amylin antagonists and agonists
11/24/1994	WO1994026290A1 Cytokine designated 4-1bb ligand and human receptor that binds thereto
11/24/1994	WO1994026289A1 Allogeneic and xenogeneic transplantation
11/24/1994	WO1994026287A1 Purification of plasma proteins
11/24/1994	WO1994026132A1 Method and composition for inhibiting escherichia coli in food products
11/24/1994	WO1994026107A1 Psychosis protecting nucleic acid, peptides, compositions and method of use
11/24/1994	WO1994026106A1 Novel tracheal antimicrobial peptides
11/24/1994	WO1994026100A1 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
11/24/1994	WO1994023043A3 Control of plant abscission and pod dehiscence
11/24/1994	WO1994023035A3 Recombinant timothy grass pollen allergen phl p ii
11/24/1994	WO1994023034A3 Variant insulin-like growth factor I receptor subunits and methods for use thereof
11/24/1994	WO1994020512A3 Analogs for specific oligosaccharide-protein interactions and uses therefor
11/24/1994	WO1994019464A3 Human dna sequence encoding a kidney atp-dependent potassium channel
11/24/1994	WO1994016073A3 Methods and reagents for inhibiting furin endoprotease
11/24/1994	WO1994015961A3 Synthetic amphipathic peptides with antimicrobial activity
11/24/1994	CA2555020A1 Inhibition of migration of inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	CA2165051A1 Dna encoding two fish neuropeptides
11/24/1994	CA2163105A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	CA2163020A1 Novel opioid peptide inhibitors
11/24/1994	CA2162928A1 Von hippel-lindau (vhl) disease gene and corresponding cdna and methods for detecting carriers of the vhl disease gene
11/24/1994	CA2162867A1 A gene expression system utilizing an rna polymerase prebound to dna
11/24/1994	CA2162865A1 Method for recombinant production of biologically active polypeptides
11/24/1994	CA2162721A1 Expansins, proteins that catalyze plant cell wall expansion and weakening of paper fiber connections
11/24/1994	CA2162664A1 Hybrid picornaviruses expressing chlamydial epitopes
11/24/1994	CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	CA2162121A1 Assay for cardiac troponin i
11/24/1994	CA2162113A1 Processes and intermediate compounds useful for the preparation of platelet glycoprotein iib/iiia inhibitors
11/24/1994	CA2162022A1 Processes for producing an enzyme
11/24/1994	CA2161973A1 Yeast strain and methods for expressing heterologous proteins in yeast
11/24/1994	CA2161807A1 Bmp-10 compositions
11/24/1994	CA2140354A1 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
11/24/1994	CA2139651A1 Amylin antagonists and agonists
11/23/1994	EP0625580A1 Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient
11/23/1994	EP0625577A1 Heterologous polypeptides expressed in filamentous fungi, processes for their preparation, and vectors for their preparation
11/23/1994	EP0625575A2 Fem A gene of staphylococcus epidermidis, fem A protein, and vectors of microorganisms comprising the fem A gene
11/23/1994	EP0625574A1 Production for biologically active polypeptide
11/23/1994	EP0625573A1 Novel dna, polypeptide coded for thereby, and method of detecting both
11/23/1994	EP0625354A1 Medical preparation containing the subunit p40 of interleukin 12
11/23/1994	EP0625212A1 Methods of detecting alzheimer's disease
11/23/1994	EP0625210A1 Nucleotide sequences and materials and methods for the diagnosis of myotonic dystrophy
11/23/1994	EP0625207A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)
11/23/1994	EP0625204A1 Hepatitis therapeutics
11/23/1994	EP0625203A1 Synthetic haemophilus influenzae conjugate vaccine
11/23/1994	EP0625202A1 Serum-human albumin, preparation and utilization
11/23/1994	EP0625199A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium
11/23/1994	EP0625198A1 EXPRESSION OF OSTEOGENIC FACTOR OP-1 IN CELLS OF $i(SPODOPTERA FRUGIPERDA) INFECTED WITH RECOMBINANT BACULOVIRUS
11/23/1994	EP0625197A1 Dna encoding kappa-casein, process for obtaining the protein and use thereof
11/23/1994	EP0625196A1 Neurotrophic factor
11/23/1994	EP0625195A1 Therapy of central nervous system by genetically modified cells
11/23/1994	EP0625194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide.
11/23/1994	EP0625193A1 Insecticidally effective peptides
11/23/1994	EP0625191A1 Mycobacterial species-specific reporter mycobacteriophages
11/23/1994	EP0625165A1 Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis

1 ... 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 ... 2916